These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25602897)

  • 1. Impact of regulatory interventions to reduce intake of artificial trans-fatty acids: a systematic review.
    Hendry VL; Almíron-Roig E; Monsivais P; Jebb SA; Neelon SE; Griffin SJ; Ogilvie DB
    Am J Public Health; 2015 Mar; 105(3):e32-42. PubMed ID: 25602897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of dietary trans-fat reduction interventions.
    Hyseni L; Bromley H; Kypridemos C; O'Flaherty M; Lloyd-Williams F; Guzman-Castillo M; Pearson-Stuttard J; Capewell S
    Bull World Health Organ; 2017 Dec; 95(12):821-830G. PubMed ID: 29200523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. trans Fatty acids in the Canadian food supply: an updated analysis.
    Arcand J; Scourboutakos MJ; Au JT; L'Abbe MR
    Am J Clin Nutr; 2014 Oct; 100(4):1116-23. PubMed ID: 25099549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intake recommendations and labeling of trans fat in processed foods in Brazil: analysis of official documents].
    Silveira BM; Proença RP
    Rev Saude Publica; 2012 Oct; 46(5):923-8. PubMed ID: 23128270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mandatory trans fat labeling regulations and nationwide product reformulations to reduce trans fatty acid content in foods contributed to lowered concentrations of trans fat in Canadian women's breast milk samples collected in 2009-2011.
    Ratnayake WN; Swist E; Zoka R; Gagnon C; Lillycrop W; Pantazapoulos P
    Am J Clin Nutr; 2014 Oct; 100(4):1036-40. PubMed ID: 25057152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of recommending certain replacement or alternative fats.
    Skeaff CM
    Eur J Clin Nutr; 2009 May; 63 Suppl 2():S34-49. PubMed ID: 19424217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of policies for reducing dietary trans fat: a systematic review of the evidence.
    Downs SM; Thow AM; Leeder SR
    Bull World Health Organ; 2013 Apr; 91(4):262-9H. PubMed ID: 23599549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans fatty acids content and fatty acid profiles in the selected food products from Korea between 2005 and 2008.
    Lee JH; Adhikari P; Kim SA; Yoon T; Kim IH; Lee KT
    J Food Sci; 2010 Sep; 75(7):C647-52. PubMed ID: 21535532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of a public-private partnership to reduce artificial trans fatty acids in England, 2011-16.
    Knai C; James L; Petticrew M; Eastmure E; Durand MA; Mays N
    Eur J Public Health; 2017 Aug; 27(4):605-608. PubMed ID: 28339665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Margarines and Fast-Food French Fries: Low Content of trans Fatty Acids.
    Astiasarán I; Abella E; Gatta G; Ansorena D
    Nutrients; 2017 Jun; 9(7):. PubMed ID: 28657612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of local, state, and national government legislation restricting trans fats.
    Assaf RR
    Clin Ther; 2014 Mar; 36(3):328-32. PubMed ID: 24636818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labeling of trans fatty acid content in food, regulations and limits-the FDA view.
    Moss J
    Atheroscler Suppl; 2006 May; 7(2):57-9. PubMed ID: 16713387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trance(s)--music and more].
    Stahl Z; Grotto I; Moran D; Ginsberg A
    Harefuah; 2013 Dec; 152(12):732-6, 751. PubMed ID: 24482999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-fatty acids, dangerous bonds for health? A background review paper of their use, consumption, health implications and regulation in France.
    Menaa F; Menaa A; Menaa B; Tréton J
    Eur J Nutr; 2013 Jun; 52(4):1289-302. PubMed ID: 23269652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On account of trans fatty acids and cardiovascular disease risk - There is still need to upgrade the knowledge and educate consumers.
    Niforou A; Magriplis E; Klinaki E; Niforou K; Naska A
    Nutr Metab Cardiovasc Dis; 2022 Aug; 32(8):1811-1818. PubMed ID: 35753860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils.
    Mozaffarian D; Clarke R
    Eur J Clin Nutr; 2009 May; 63 Suppl 2():S22-33. PubMed ID: 19424216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trans fatty acids: current contents in Canadian foods and estimated intake levels for the Canadian population.
    Ratnayake WM; L'Abbe MR; Farnworth S; Dumais L; Gagnon C; Lampi B; Casey V; Mohottalage D; Rondeau I; Underhill L; Vigneault M; Lillycrop W; Meleta M; Wong LY; Ng T; Gao Y; Kwong K; Chalouh S; Pantazopoulos P; Gunaratna H; Rahardja A; Blagden R; Roscoe V; Krakalovich T; Neumann G; Lombaert GA
    J AOAC Int; 2009; 92(5):1258-76. PubMed ID: 19916364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimming trans fat.
    Winterfeld A
    NCSL Legisbrief; 2007; 15(32):1-2. PubMed ID: 17824130
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of the regulation on trans fatty acid content in Danish food.
    Leth T; Jensen HG; Mikkelsen AA; Bysted A
    Atheroscler Suppl; 2006 May; 7(2):53-6. PubMed ID: 16713397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trans fatty acid elimination policy in member states of the Eurasian Economic Union: Implementation challenges and capacity for enforcement.
    Demin A; Løge B; Zhiteneva O; Nishida C; Whiting S; Rippin H; Delles C; Karymbaeva S; Wickramasinghe K; Breda J
    J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1328-1337. PubMed ID: 32677762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.